Pulling SEC filings + quote and writing the call…

Virtuix Holdings Inc.
Next earnings Jun 25, 2026 (before open) · consensus $-0.40 EPS, $944K rev
Last earnings -12.3% on 2026-06-26
Pre-scale VR-treadmill maker burning ~$9.5M/yr on $4.25M revenue, ~1yr cash runway, 180% dilution — at 14.8x sales it's uninvestable.
Revenue $4.25M · FY2026
Virtuix is a 2013-vintage, just-IPO'd (Prospectus dated Jan 26, 2026) micro-cap selling omni-directional VR treadmills, and the numbers describe a pre-commercial company, not a business at scale. FY2026 revenue was just $4.25M (+18.4%), against a net loss of $16.8M that actually widened from FY2025's $14.6M loss. Net margin is -395% and operating margin -242.7%; the company itself states it has lost money since inception, carries a $79.3M accumulated deficit, and 'anticipate[s] continued operating losses' in FY2027. There is real product progress — gross profit swung positive to $1.05M (24.6% margin, well below management's 40–70% targets) and an Omni One consumer/enterprise/defense strategy — but the scale is tiny and unprofitable.
The balance sheet is the disqualifier. Operating cash flow was -$9.5M against $9.47M of cash on hand — roughly one year of runway before another raise. The IPO already inflated shares 180% YoY (cash +1,882%, equity +484% are IPO artifacts, not operating improvement), so existing holders should expect further dilution to keep the lights on. Equity is a thin $3.05M against $11.7M of liabilities (3.84x) including $8.54M of long-term debt, and ROE is -551%. Tellingly, R&D was cut 61% to $846K in the very year management says its defense product VTW 'is still in development' — a cash-preservation move that sits awkwardly against the growth story.
Is VTIX a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY25 | FY26 |
|---|---|---|
| Revenue | $3.59M | $4.25M |
| Gross profit | -$227K | $1.05M |
| Operating income | -$14.2M | -$10.3M |
| Net income | -$14.6M | -$16.8M |
| Diluted EPS | -$1.78 | -$0.73 |
| Net margin | -408.0% | -395.0% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Reported FY2026 results: revenue +18% to $4.25M, but net loss widened to $16.8M
FY2026: revenue +18%, cash $9.5M, but loss $16.8M and shares +180% dilution
Entered a material definitive agreement (new contract/partnership)
New financing created a direct debt obligation, adding leverage
Filed S-1 to register shares — potential dilution for existing holders
Other-events disclosure (business/product press release)
Q3 FY2026: continued operating losses ahead of public listing
Sources: SEC EDGAR (CIK 0001606242, latest 10-K filed 2026-06-25) · EODHD · Proprietary analysis · as of 6/30/2026, 12:13:18 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 30, 2026, 8:13 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 15 sales
| 2026-05-06 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 20.3K @ $3.58 | $72.6K |
| 2026-05-05 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 77.4K @ $4.04 | $313K |
| 2026-05-04 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 24.2K @ $3.50 | $84.6K |
| 2026-04-30 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 13.6K @ $3.40 | $46.1K |
| 2026-04-29 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 18.7K @ $3.32 | $62.1K |
| 2026-04-28 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 15.9K @ $3.52 | $56.0K |
| 2026-04-27 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 28.7K @ $3.69 | $106K |
| 2026-04-23 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 61.8K @ $4.58 | $283K |
| 2026-04-22 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 49.1K @ $5.96 | $293K |
| 2026-04-21 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 113K @ $6.96 | $783K |
| 2026-04-20 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 25.0K @ $6.62 | $165K |
| 2026-04-16 | Goetgeluk Jan Roger Chief Executive Officer | Sell | 9.32K @ $6.14 | $57.2K |
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.